| __timestamp | Veracyte, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 40786000 | 1802274 |
| Thursday, January 1, 2015 | 47876000 | 2512761 |
| Friday, January 1, 2016 | 52035000 | 2894488 |
| Sunday, January 1, 2017 | 55348000 | 8096274 |
| Monday, January 1, 2018 | 65276000 | 7985229 |
| Tuesday, January 1, 2019 | 82720000 | 8994597 |
| Wednesday, January 1, 2020 | 89118000 | 29772000 |
| Friday, January 1, 2021 | 181193000 | 33907000 |
| Saturday, January 1, 2022 | 174078000 | 26579000 |
| Sunday, January 1, 2023 | 184232000 | 49868547 |
Igniting the spark of knowledge
In the dynamic world of biotechnology, understanding financial trends is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Verona Pharma plc and Veracyte, Inc. over the past decade. From 2014 to 2023, Veracyte, Inc. has consistently outpaced Verona Pharma in SG&A spending, with a notable increase of over 350% from 2014 to 2023. In contrast, Verona Pharma's expenses grew by approximately 2,670% during the same period, reflecting its aggressive expansion strategy.
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Veracyte, Inc.
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
PTC Therapeutics, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and Arrowhead Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Geron Corporation
Comparing SG&A Expenses: Veracyte, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Breaking Down SG&A Expenses: Veracyte, Inc. vs Viridian Therapeutics, Inc.